MRI of the prostate: Clinical relevance and emerging applications

MRI of the prostate can aid in many aspects of prostate cancer management, from initial detection to treatment planning and follow‐up. This review describes the current strengths and limitations of conventional anatomic and molecular MR imaging techniques (including MR spectroscopic imaging and dynamic contrast‐enhanced imaging) for aiding prostate cancer management. It also describes promising emerging approaches for acquiring, analyzing, and applying MR imaging data, and the major research and educational efforts that will be required to realize the potential of prostate MR imaging in routine clinical practice. J. Magn. Reson. Imaging 2011;33:258–274. © 2011 Wiley‐Liss, Inc.

[1]  Peter Wust,et al.  Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. , 2007, European urology.

[2]  Kemal Tuncali,et al.  Late genitourinary and gastrointestinal toxicity after magnetic resonance image‐guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy , 2003, Cancer.

[3]  G. Parker,et al.  Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience. , 2004, Radiology.

[4]  C C Ling,et al.  High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.

[5]  H. Hricak,et al.  Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. , 2007, Radiology.

[6]  D. Rosenthal Radiologic diagnosis of bone metastases , 1997, Cancer.

[7]  Alexandra L Hanlon,et al.  Prostate cancer radiotherapy dose response: an update of the fox chase experience. , 2004, The Journal of urology.

[8]  J Kurhanewicz,et al.  Dynamic contrast‐enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI , 2005, Magnetic resonance in medicine.

[9]  H. Huisman,et al.  Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.

[10]  A. D'Amico,et al.  Transperineal magnetic resonance image guided prostate biopsy. , 2000, The Journal of urology.

[11]  B. Misselwitz MR contrast agents in lymph node imaging. , 2006, European journal of radiology.

[12]  J. Moul,et al.  CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. , 1998, The Journal of urology.

[13]  Steven J Haker,et al.  Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer. , 2005, Urology.

[14]  P. Therasse,et al.  Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Tristan Barrett,et al.  Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. , 2007, AJR. American journal of roentgenology.

[16]  E Bellon,et al.  The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[17]  D P Dearnaley,et al.  Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging. , 2001, Radiology.

[18]  M V Knopp,et al.  Dynamic contrast-enhanced magnetic resonance imaging in oncology. , 2001, Topics in magnetic resonance imaging : TMRI.

[19]  D P Dearnaley,et al.  Comparison of MRI with CT for the radiotherapy planning of prostate cancer: a feasibility study. , 1999, The British journal of radiology.

[20]  Emmanuel Itti,et al.  Lymph node imaging: basic principles. , 2006, European journal of radiology.

[21]  H. Hricak,et al.  Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. , 2007, International journal of radiation oncology, biology, physics.

[22]  H. Hricak,et al.  MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. , 2005, The British journal of radiology.

[23]  Masoom A Haider,et al.  Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.

[24]  P. Carroll,et al.  Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. , 2004, Radiology.

[25]  M. Kattan,et al.  Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy , 2009, BJU international.

[26]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.

[27]  P. Walsh Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. , 2005, The Journal of urology.

[28]  Masoom A Haider,et al.  Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[29]  M. Cooperberg,et al.  The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. , 2004, The Journal of urology.

[30]  M. Kattan,et al.  A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. , 1998, Journal of the National Cancer Institute.

[31]  T. Scheenen,et al.  Prostate cancer: local staging at 3-T endorectal MR imaging--early experience. , 2006, Radiology.

[32]  Jason A Koutcher,et al.  Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. , 2009, Radiology.

[33]  Jing Chen,et al.  Monitoring prostate thermal therapy with diffusion‐weighted MRI , 2008, Magnetic resonance in medicine.

[34]  Michael W Kattan,et al.  Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. , 2004, Radiology.

[35]  P. Scardino,et al.  The clinical features of anterior prostate cancers , 2006, BJU international.

[36]  Katarzyna J Macura,et al.  MR-guided biopsy of the prostate: an overview of techniques and a systematic review. , 2008, European urology.

[37]  Nobuhiko Hata,et al.  Magnetic Resonance-guided Prostate Interventions , 2005, Topics in magnetic resonance imaging : TMRI.

[38]  D P Dearnaley,et al.  Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.

[39]  Alexandra L Hanlon,et al.  Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings. , 2002, Urology.

[40]  M. V. D. van den Brekel Lymph node metastases: CT and MRI. , 2000, European journal of radiology.

[41]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[42]  S. Herrell Interventional robotic systems: Applications and technology state-of-the-art: Cleary K, Melzer A, Watson V, Kronreif G, Stoianovici D, Department of Radiology, Imaging Science and Information Systems Center, Georgetown University Medical Center, Washington, DC , 2007 .

[43]  H Okamura,et al.  Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. , 2000, Radiology.

[44]  J. Pouliot,et al.  Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. , 2004, International journal of radiation oncology, biology, physics.

[45]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[46]  Thomas Wheeler,et al.  An analysis of men with clinically localized prostate cancer who deferred definitive therapy. , 2004, The Journal of urology.

[47]  Peter Choyke,et al.  Challenges in clinical prostate cancer: role of imaging. , 2009, AJR. American journal of roentgenology.

[48]  Riwa Kishimoto,et al.  ADC value and diffusion tensor imaging of prostate cancer: Changes in carbon‐ion radiotherapy , 2008, Journal of magnetic resonance imaging : JMRI.

[49]  M. Brekel Lymph node metastases: CT and MRI. , 2000 .

[50]  Ciprian Catana,et al.  Simultaneous PET-MRI: a new approach for functional and morphological imaging , 2008, Nature Medicine.

[51]  Usha Sinha,et al.  In vivo diffusion tensor imaging of the human prostate , 2004, Magnetic resonance in medicine.

[52]  J R Griffiths,et al.  BOLD MRI of human tumor oxygenation during carbogen breathing , 2001, Journal of magnetic resonance imaging : JMRI.

[53]  P. Carroll,et al.  Multiparametric magnetic resonance imaging in prostate cancer: present and future , 2008, Current opinion in urology.

[54]  Jason A Koutcher,et al.  Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. , 2005, Radiology.

[55]  L Verhey,et al.  Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[56]  C. Claussen,et al.  Simultaneous Mr/pet Imaging of the Human Brain: Feasibility Study 1 , 2022 .

[57]  M. Kattan,et al.  Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. , 2006, Radiology.

[58]  John M Pauly,et al.  Hyperpolarized C‐13 spectroscopic imaging of the TRAMP mouse at 3T—Initial experience , 2007, Magnetic resonance in medicine.

[59]  Katarzyna J Macura,et al.  Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.

[60]  I. Kaplan,et al.  Real time MRI-ultrasound image guided stereotactic prostate biopsy. , 2002, Magnetic resonance imaging.

[61]  Nobuhiko Hata,et al.  MR‐guided prostate interventions , 2008, Journal of magnetic resonance imaging : JMRI.

[62]  D. Beyersdorff,et al.  MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. , 2005, Radiology.

[63]  A. Neugut,et al.  Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. , 1999, Urology.

[64]  Laura Curiel,et al.  Control of prostate cancer by transrectal HIFU in 227 patients. , 2007, European urology.

[65]  Mark Rijpkema,et al.  Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging. , 2002, International journal of radiation oncology, biology, physics.

[66]  B R Rosen,et al.  NMR imaging of changes in vascular morphology due to tumor angiogenesis , 1998, Magnetic resonance in medicine.

[67]  Guglielmo Manenti,et al.  Diffusion Tensor Magnetic Resonance Imaging of Prostate Cancer , 2007, Investigative radiology.

[68]  Chris J. Diederich,et al.  Magnetic Resonance-Guided High-Intensity Ultrasound Ablation of the Prostate , 2006, Topics in magnetic resonance imaging : TMRI.

[69]  Leen Paelinck,et al.  The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[70]  Anke M Hövels,et al.  Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR Imaging at 1.5 and 3.0 T: early experience. , 2006, Radiology.

[71]  Pamela Catton,et al.  Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer. , 2004, International journal of radiation oncology, biology, physics.

[72]  M. Kattan,et al.  Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. , 2005, The Journal of urology.

[73]  Patrick W McLaughlin,et al.  Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI. , 2005, International journal of radiation oncology, biology, physics.

[74]  J. Kurhanewicz,et al.  Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. , 2004, Radiology.

[75]  M. Harisinghani,et al.  Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[76]  A. Prando Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume , 2009 .

[77]  P. Hoskin,et al.  Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[78]  A. Cesinaro,et al.  3-T MRI with phased-array coil in local staging of prostatic cancer. , 2008, Academic radiology.

[79]  Junqian Xu,et al.  Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans , 2009, Magnetic resonance in medicine.

[80]  Gary Luxton,et al.  Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. , 2004, International journal of radiation oncology, biology, physics.

[81]  Harry J de Koning,et al.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.

[82]  P. Hoskin,et al.  The modification of human tumour blood flow using pentoxifylline, nicotinamide and carbogen. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[83]  A R Padhani,et al.  Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. , 2001, Clinical radiology.

[84]  P. Carroll,et al.  Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. , 1994, Radiology.

[85]  J. Kurhanewicz,et al.  Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score , 2007, European Radiology.

[86]  G. Hanks,et al.  Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer. , 1999, Urology.

[87]  Guoying Liu,et al.  Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report. , 2005, Cancer research.

[88]  G. De Meerleer,et al.  Magnetic resonance imaging (MRI) anatomy of the prostate and application of MRI in radiotherapy planning. , 2007, European journal of radiology.

[89]  D J Collins,et al.  Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans , 2009, British Journal of Cancer.

[90]  J Kurhanewicz,et al.  Time‐dependent effects of hormone‐deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.

[91]  Dennis W J Klomp,et al.  Initial Experience of 3 Tesla Endorectal Coil Magnetic Resonance Imaging and 1H-Spectroscopic Imaging of the Prostate , 2004, Investigative radiology.

[92]  A W Partin,et al.  Disease progression following radical prostatectomy in men with Gleason score 7 tumor. , 1998, The Journal of urology.

[93]  Henkjan J Huisman,et al.  Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.

[94]  Rémi Souchon,et al.  Transrectal high-intensity focused ultrasound ablation of prostate cancer: effective treatment requiring accurate imaging. , 2007, European journal of radiology.

[95]  J R Thornbury,et al.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. , 1997, Radiology.

[96]  Clare Allen,et al.  Dynamic contrast enhanced MRI in prostate cancer. , 2007, European journal of radiology.

[97]  R. Franklin,et al.  The Intermediary Metabolism of the Prostate: A Key to Understanding the Pathogenesis and Progression of Prostate Malignancy , 2000, Oncology.

[98]  Bernd Hamm,et al.  Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. , 2002, Radiology.

[99]  W. De Neve,et al.  Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. , 2004, International journal of radiation oncology, biology, physics.

[100]  Silvia D. Chang,et al.  Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. , 2002, Radiology.

[101]  Bong Hyun Chung,et al.  Quantum dot‐based protein micro‐ and nanoarrays for detection of prostate cancer biomarkers , 2008, Proteomics.

[102]  H. Hricak,et al.  Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. , 2006, Radiology.

[103]  Thomas Hambrock,et al.  Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. , 2007, Radiology.

[104]  C. Reddy,et al.  Recurrence‐free survival rates after external‐beam radiotherapy for patients with clinical T1–T3 prostate carcinoma in the prostate‐specific antigen era , 2004, Cancer.

[105]  K. Pummer,et al.  Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the partin tables , 2009, Acta radiologica.

[106]  D. Stoianovici,et al.  Interventional robotic systems: Applications and technology state‐of‐the‐art , 2006, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[107]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[108]  K. Stine,et al.  Detection of free prostate specific antigen (fPSA) on a nanoporous gold platform. , 2008, The Analyst.

[109]  D. Collins,et al.  Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.

[110]  Peter Gibbs,et al.  Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.

[111]  Tim Jones,et al.  The role of PET scanning in radiotherapy , 2005 .

[112]  O. Hélénon,et al.  Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. , 2002, Radiology.

[113]  C. Kim,et al.  Localization of Prostate Cancer Using 3T MRI: Comparison of T2-Weighted and Dynamic Contrast-Enhanced Imaging , 2006, Journal of computer assisted tomography.

[114]  Evis Sala,et al.  Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.

[115]  Jelle O. Barentsz,et al.  Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.

[116]  D. Chia,et al.  Direct electronic detection of prostate-specific antigen in serum. , 2007, Small.

[117]  M. Kattan,et al.  Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. , 2000, The Journal of urology.

[118]  Ralph Weissleder,et al.  Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.

[119]  S. Shariat,et al.  Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. , 2001, Radiology.

[120]  B. Issa,et al.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[121]  H M Pollack,et al.  Magnetic resonance imaging of the prostate gland , 1990, Urologic radiology.

[122]  M. Langer,et al.  Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. , 2005, European journal of radiology.

[123]  Toyoaki Uchida,et al.  Treatment of localized prostate cancer using high‐intensity focused ultrasound , 2006, BJU international.

[124]  A. D'Amico,et al.  Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. , 1998, International journal of radiation oncology, biology, physics.

[125]  Michael Scott,et al.  Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics , 2007, International journal of nanomedicine.

[126]  J Kurhanewicz,et al.  Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. , 2001, Radiology.

[127]  J Kurhanewicz,et al.  Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. , 1998, Radiology.

[128]  M Dattoli,et al.  A simple method to stabilize the prostate during transperineal prostate brachytherapy. , 1997, International journal of radiation oncology, biology, physics.

[129]  Gabor Fichtinger,et al.  Robotic Assistant for Transperineal Prostate Interventions in 3T Closed MRI , 2007, MICCAI.

[130]  Simon R Cherry,et al.  Multimodality imaging: beyond PET/CT and SPECT/CT. , 2009, Seminars in nuclear medicine.

[131]  A. Simmons,et al.  Effects of three different doses of a bolus injection of gadodiamide: assessment of regional cerebral blood volume maps in a blinded reader study. , 2000, AJNR. American journal of neuroradiology.

[132]  P. Carroll,et al.  Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.

[133]  Jean-François Geschwind,et al.  MRI guidance of focused ultrasound therapy of uterine fibroids: early results. , 2004, AJR. American journal of roentgenology.

[134]  J. Roy,et al.  Prostate gland motion and deformation caused by needle placement during brachytherapy. , 2002, Brachytherapy.

[135]  M. Kattan,et al.  The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis , 2007, BJU international.

[136]  M. Kattan,et al.  Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. , 2003, Radiology.

[137]  Michael W Kattan,et al.  Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. , 2004, Radiology.

[138]  A. Partin,et al.  Comparison of clinical staging algorithms and 111Indium‐capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients , 1999, Cancer.

[139]  J. Kurhanewicz,et al.  Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. , 2004, International journal of radiation oncology, biology, physics.

[140]  J Kurhanewicz,et al.  Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. , 1995, Urology.